The round, which values Databricks at $US62 billion, was led by Temasek, Macquarie Capital and Qatar’s sovereign wealth fund ...

In a report released on January 21, Richard Chamberlain from RBC Capital maintained a Buy rating on Next plc (NXT – Research Report), with a ...

In a report released on January 20, Rishi Jaluria from RBC Capital maintained a Buy rating on Clearwater Analytics Holdings (CWAN – Research ...

Issuance was led by a $2 billion retail pricing from the University of California in the negotiated market and a $1.2 billion competitive deal from Washington.

Dyne Therapeutics Inc (DYN) stock saw a modest uptick, ending the day at $14.55 which represents a slight increase of $0.42 or 2.97% from the prior close of $14.13. The stock opened at $14.3 and ...

Hedge funds have positioned for Donald Trump's U.S. presidency with their highest levels of borrowing since 2010, while ...

RBC Capital Markets adjusted its stance on Intra-Cellular Therapies shares, downgrading the biopharmaceutical company from Outperform to Sector Perform. The firm, however, raised its price target on ...

U.S. stock-trading hedge funds kicked off the week with gross leverage levels in their highest range since 2010.

T-Mobile Us Inc (TMUS) stock saw a modest uptick, ending the day at $218.97 which represents a slight increase of $3.22 or 1.49% from the prior close of $215.75. The stock opened at $219.21 and ...

RBC Capital Markets adjusted their outlook on Morgan Stanley (NYSE:MS) shares, raising the price target from $122.00 to ...

Standard Chartered printed a $1bn four year non-call three bond at 105bp over US Treasuries, and a $1bn 11 year non-call 10 ...

Morgan Stanley's profit more than doubled in the fourth quarter, fueled by a wave of dealmaking and stock sales that drove ...